Randomised trial of erythromycin on the development of chronic lung disease in preterm infants
a Neonatal Unit, Simpson Memorial Maternity
Pavilion, Lauriston Place, Edinburgh EH3 9YW, b Department Child Life and Health, University of Edinburgh, c Department Medical Microbiology, University of Edinburgh
Correspondence to: Dr A J Lyon.
Accepted 2 July 1997
AIMS
To determine if erythromycin given from birth
reduces the inflammatory response and the incidence and severity of
chronic lung disease.
METHODS
Seventy five infants less than 30 weeks of
gestation and ventilated from birth for lung disease were randomly
assigned to receive erythromycin intravenously for 7 days or to no
treatment. Ureaplasma urealyticum was detected in tracheal
secretions by culture and polymerase chain reaction. Differential cell
counts were obtained from bronchoalveolar lavage fluid collected daily for 5 days and concentrations of the cytokines interluekins IL-1
and
IL-8, and tumour necrosis factor
(TNF-
) were measured. Chronic
lung disease (CLD) was defined as oxygen dependency at 36 weeks of gestation.
RESULTS
Nine infants (13%) were positive for
U urealyticum. The inflammatory cytokines in the lungs
increased over the first 5 days of life in all babies, but no
association was found between their concentrations and the development
of CLD. Those treated with erythromycin showed no significant
differences from the non- treated group in the differential cell counts
or concentrations of the cytokines. The two groups had a similar
incidence of CLD. Babies infected with U urealyticum did
not have a more pronounced cytokine response than those without
infection. Chorioamnionitis was associated with significantly higher
concentrations of IL-1
and IL-8 on admission: these babies had less
severe acute lung disease and developed significantly less CLD.
CONCLUSIONS
U urealyticum in the
trachea was not associated with an increased inflammatory response in
preterm infants. Erythromycin did not reduce the incidence or severity
of CLD.
© 1998 by Archives of Disease in Childhood
This article has been cited by other articles:
-
Lahra, M. M., Beeby, P. J., Jeffery, H. E.
(2009). Intrauterine Inflammation, Neonatal Sepsis, and Chronic Lung Disease: A 13-Year Hospital Cohort Study. Pediatrics
123: 1314-1319
[Abstract] [Full Text] -
Waites, K. B., Katz, B., Schelonka, R. L.
(2005). Mycoplasmas and Ureaplasmas as Neonatal Pathogens. Clin. Microbiol. Rev.
18: 757-789
[Abstract] [Full Text] -
Christou, H., Brodsky, D.
(2005). Lung Injury and Bronchopulmonary Dysplasia in Newborn Infants. J Intensive Care Med
20: 76-87
[Abstract] -
Theilen, U, Lyon, A J, Fitzgerald, T, Hendry, G M A, Keeling, J W
(2004). Infection with Ureaplasma urealyticum: is there a specific clinical and radiological course in the preterm infant?. Arch. Dis. Child. Fetal Neonatal Ed.
89: F163-F167
[Abstract] [Full Text] -
Ng, P C, So, K W, Fung, K S C, Lee, C H, Fok, T F, Wong, E, Wong, W, Cheung, K L, Cheng, A F B
(2001). Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed.
84: 177F-182
[Abstract] [Full Text] -
Hannaford, K., Todd, D. A, Jeffery, H., John, E., Blyth, K., Gilbert, G. L
(1999). Role of Ureaplasma urealyticum in lung disease of prematurity. Arch. Dis. Child. Fetal Neonatal Ed.
81: 162F-167
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



